Tenecteplase: stability and bioactivity of thawed or diluted solutions used in peripheral thrombolysis.

J Vasc Interv Radiol

Department of Vascular Medicine, Genentech, Inc., South San Francisco, 94080-4990, USA.

Published: April 2003

Purpose: Tenecteplase (TNK; TNKase) is a third-generation plasminogen activator approved for acute myocardial infarction with an enhanced safety profile compared to alteplase. The stability and bioactivity of reconstituted frozen/thawed and diluted tenecteplase solutions used in noncoronary peripheral thrombolysis was determined.

Materials And Methods: Lyophilized TNK was freshly reconstituted in sterile water (5 mg/mL) and used as control. In freeze/thaw studies, reconstituted TNK aliquots were stored frozen for 4 weeks at -20 degrees C, thawed at ambient temperature, and assayed with and without an additional freeze/thaw cycle. Additional freshly reconstituted TNK aliquots were assayed after six freeze/thaw cycles when frozen at two separate temperatures (-20 degrees and -70 degrees C) and thawed at 2-8 degrees C or ambient temperature. In dilution studies, reconstituted TNK was diluted in 500-mL commercially available normal saline solution bags to concentrations of 0.01, 0.02, and 0.05 mg/mL. Samples were assayed after 0, 8, and 24 hours at ambient temperature. Optical clarity, pH, protein concentration, particle counts, and in-vitro clot-lysis assays were performed. Protein monomer (%), single-chain protein (%), and particle counts were performed in freeze/thaw studies.

Results: Frozen/thawed TNK aliquots met all specifications as freshly reconstituted product. For dilution studies (0.01, 0.02, and 0.05 mg/mL), the recovered protein retained 83%-100% bioactivity after 24 hours. The recovered protein rates over the course of 24 hours (relative to target concentration) were 70%-75%, 80%-85%, and 94%-95% at 0.01, 0.02, and 0.05 mg/mL, respectively. Assayed solutions were clear/colorless at all concentrations and time points.

Conclusion: TNK is fully active after reconstitution and freezing/thawing. TNK dilutions used in clinical practice (0.01-0.05 mg/mL) demonstrated retention of biologic activity at 24 hours without precipitates.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.rvi.0000064843.87207.f7DOI Listing

Publication Analysis

Top Keywords

freshly reconstituted
12
reconstituted tnk
12
tnk aliquots
12
ambient temperature
12
001 002
12
002 005
12
005 mg/ml
12
stability bioactivity
8
peripheral thrombolysis
8
tnk
8

Similar Publications

Article Synopsis
  • Open nanoshells, or 'semi shells', have special plasmonic properties due to their asymmetric structure and are typically made using complex methods, but this study introduces a simpler one-step process for creating them.
  • The newly fabricated PEGylated semi-shells show strong localized surface plasmon resonance under near-infrared light and remain effective even after being preserved for long periods, demonstrating safety in mice with no toxic effects post intravenous injection.
  • In animal trials, these PEGylated semi-shells exhibited high photothermal efficiency, leading to complete eradication of primary breast tumors without affecting critical organs, and resulted in a 75% survival rate without complications for up to 90 days
View Article and Find Full Text PDF

Piracanjuba (Brycon orbignyanus) is an endangered fish species from the Neotropical region. The establishment of a cryobank using spermatogonial stem cells (SSCs) and subsequent production of a germline chimera is thus a promising strategy for such species. In the present work, procedures for the isolation and cryopreservation of piracanjuba SSCs and subsequent transplantation into sterile recipients were established.

View Article and Find Full Text PDF

Background: Thromboelastogram testing is increasingly being used to manage patients with massive bleeding. An earlier study found that the test results were influenced by the hematocrit (Hct) and platelet (PLT) concentrations. This study sought to determine if these factors confounded the results of a different manufacturer's thromboelastography testing.

View Article and Find Full Text PDF

Lyoprotectant Constituents Suited for Lyophilization and Reconstitution of Stem-Cell-Derived Extracellular Vesicles.

Biomater Res

February 2024

Department of Biomedical & Robotics Engineering, College of Engineering, Incheon National University, Incheon 22012, Republic of Korea.

Stem-cell-derived extracellular vesicles (EVs) are emerging as an alternative approach to stem cell therapy. Successful lyophilization of EVs could enable convenient storage and distribution of EV medicinal products at room temperature for long periods, thus considerably increasing the accessibility of EV therapeutics to patients. In this study, we aimed to identify an appropriate lyoprotectant composition for the lyophilization and reconstitution of stem-cell-derived EVs.

View Article and Find Full Text PDF

This research reveals the underlying mechanisms that make high-intensity ultrasound an effective tool to reduce the viscosity of micellar casein concentrates and to enhance the solubility of the respective powders. Micellar casein concentrates (MCC) gained great importance in the production of valuable food products with high protein content, but the processing properties of the reconstituted solutions are deficient. Even though several presumptions were established, the reasons why ultrasound is able to reduce the product viscosity and what limitations occur when using sonication technology are still not clear yet.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!